Annual SGA
$4.77 M
-$1.20 M-20.07%
December 31, 2023
Summary
- As of February 7, 2025, CNSP annual SGA is $4.77 million, with the most recent change of -$1.20 million (-20.07%) on December 31, 2023.
- During the last 3 years, CNSP annual SGA has risen by +$376.60 thousand (+8.57%).
- CNSP annual SGA is now -20.07% below its all-time high of $5.97 million, reached on December 31, 2022.
Performance
CNSP SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$1.38 M
-$27.70 K-1.96%
September 30, 2024
Summary
- As of February 7, 2025, CNSP quarterly SGA is $1.38 million, with the most recent change of -$27.70 thousand (-1.96%) on September 30, 2024.
- Over the past year, CNSP quarterly SGA has increased by +$260.60 thousand (+23.20%).
- CNSP quarterly SGA is now -35.71% below its all-time high of $2.15 million, reached on December 31, 2022.
Performance
CNSP Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$299.57 M
-$17.06 M-6.04%
September 30, 2024
Summary
- As of February 7, 2025, CNSP TTM SGA is -$299.57 million, with the most recent change of -$17.06 million (-6.04%) on September 30, 2024.
- Over the past year, CNSP TTM SGA has dropped by -$305.38 million (-5252.20%).
- CNSP TTM SGA is now -3835.85% below its all-time high of -$7.61 million.
Performance
CNSP TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
CNSP Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -20.1% | +23.2% | -5252.2% |
| 3 y3 years | +8.6% | +12.0% | -6248.8% |
| 5 y5 years | +454.3% | +12.0% | -6248.8% |
CNSP Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -20.1% | +1.9% | -35.7% | +54.4% | -148.5% | at low |
| 5 y | 5-year | -20.1% | +141.1% | -35.7% | +54.4% | -943.6% | at low |
| alltime | all time | -20.1% | +454.3% | -35.7% | +842.7% | -3835.8% | at low |
CNS Pharmaceuticals Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $1.38 M(-2.0%) | $5.02 M(+5.5%) |
| Jun 2024 | - | $1.41 M(+26.7%) | $4.76 M(+5.1%) |
| Mar 2024 | - | $1.11 M(+0.6%) | $4.53 M(-5.1%) |
| Dec 2023 | $4.77 M(-20.1%) | $1.11 M(-1.4%) | $4.77 M(-18.0%) |
| Sep 2023 | - | $1.12 M(-4.8%) | $5.81 M(-1.5%) |
| Jun 2023 | - | $1.18 M(-13.2%) | $5.90 M(-2.7%) |
| Mar 2023 | - | $1.36 M(-36.9%) | $6.07 M(+1.6%) |
| Dec 2022 | $5.97 M(+27.5%) | $2.15 M(+77.7%) | $5.97 M(+26.7%) |
| Sep 2022 | - | $1.21 M(-9.8%) | $4.71 M(-0.5%) |
| Jun 2022 | - | $1.34 M(+6.6%) | $4.74 M(+4.3%) |
| Mar 2022 | - | $1.26 M(+40.6%) | $4.54 M(-3.0%) |
| Dec 2021 | $4.68 M | $896.30 K(-27.4%) | $4.68 M(-3.9%) |
| Sep 2021 | - | $1.24 M(+7.8%) | $4.87 M(+5.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2021 | - | $1.15 M(-18.3%) | $4.61 M(+3.7%) |
| Mar 2021 | - | $1.40 M(+29.0%) | $4.44 M(+1.1%) |
| Dec 2020 | $4.39 M(+122.0%) | $1.09 M(+12.3%) | $4.39 M(+0.0%) |
| Sep 2020 | - | $968.80 K(-1.3%) | $4.39 M(+15.7%) |
| Jun 2020 | - | $981.50 K(-27.6%) | $3.80 M(+19.1%) |
| Mar 2020 | - | $1.36 M(+24.8%) | $3.19 M(+61.1%) |
| Dec 2019 | $1.98 M(+129.9%) | $1.09 M(+190.8%) | $1.98 M(+79.7%) |
| Sep 2019 | - | $373.50 K(+0.3%) | $1.10 M(+23.3%) |
| Jun 2019 | - | $372.30 K(+153.6%) | $893.00 K(+24.6%) |
| Mar 2019 | - | $146.80 K(-29.6%) | $716.80 K(+25.8%) |
| Dec 2018 | $860.50 K | $208.60 K(+26.2%) | $570.00 K(+57.7%) |
| Sep 2018 | - | $165.30 K(-15.7%) | $361.40 K(+84.3%) |
| Jun 2018 | - | $196.10 K | $196.10 K |
FAQ
- What is CNS Pharmaceuticals annual SGA?
- What is the all time high annual SGA for CNS Pharmaceuticals?
- What is CNS Pharmaceuticals annual SGA year-on-year change?
- What is CNS Pharmaceuticals quarterly SGA?
- What is the all time high quarterly SGA for CNS Pharmaceuticals?
- What is CNS Pharmaceuticals quarterly SGA year-on-year change?
- What is CNS Pharmaceuticals TTM SGA?
- What is the all time high TTM SGA for CNS Pharmaceuticals?
- What is CNS Pharmaceuticals TTM SGA year-on-year change?
What is CNS Pharmaceuticals annual SGA?
The current annual SGA of CNSP is $4.77 M
What is the all time high annual SGA for CNS Pharmaceuticals?
CNS Pharmaceuticals all-time high annual SGA is $5.97 M
What is CNS Pharmaceuticals annual SGA year-on-year change?
Over the past year, CNSP annual SGA has changed by -$1.20 M (-20.07%)
What is CNS Pharmaceuticals quarterly SGA?
The current quarterly SGA of CNSP is $1.38 M
What is the all time high quarterly SGA for CNS Pharmaceuticals?
CNS Pharmaceuticals all-time high quarterly SGA is $2.15 M
What is CNS Pharmaceuticals quarterly SGA year-on-year change?
Over the past year, CNSP quarterly SGA has changed by +$260.60 K (+23.20%)
What is CNS Pharmaceuticals TTM SGA?
The current TTM SGA of CNSP is -$299.57 M
What is the all time high TTM SGA for CNS Pharmaceuticals?
CNS Pharmaceuticals all-time high TTM SGA is -$7.61 M
What is CNS Pharmaceuticals TTM SGA year-on-year change?
Over the past year, CNSP TTM SGA has changed by -$305.38 M (-5252.20%)